Curesponse vs Impact Biotech

Curesponse vs Impact Biotech, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Curesponse is on 55/100 and Impact Biotech on 39/100.

Curesponse logo
CuresponsePersonalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.
Try Curesponse
Impact Biotech logo
Impact BiotechDevelops and launches Padeliporfin VTP therapy for solid tumor treatment.
Try Impact Biotech

Where each one leads

Curesponse

  • our overall score: 55/100 against 39/100
  • agent readiness: 50/100 against 21/100
  • funding raised: $28.0M against $2.7M
  • LinkedIn following: 2,570 against 1,470

Impact Biotech

  • domain rating: 20/100 against 17/100
  • headcount: 42 against 14
  • headcount growth: +16.9% against -4.3%

At a glance

MeasureCuresponseImpact Biotech
What it isPersonalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.Develops and launches Padeliporfin VTP therapy for solid tumor treatment.
CategoryLife Sciences, Cancer, Genomics, Genome SequencingLife Sciences, Cancer, Therapeutics, Biotech
Sells toBusiness modelB2BB2B
OfferingPlatformSoftware
Founded20171996
HeadquartersTel Aviv, IsraelTel Aviv, Israel
StatusInactiveActive

Size, funding and growth

MeasureCuresponseImpact Biotech
Employees1442
Headcount growthLast 12 months-4.3%+16.9%
Total funding$28.0M$2.7M
Latest roundSeries BGrant
LinkedIn followers2,5701,470

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCuresponseImpact Biotech
StartupHub scoreOur 0-100 rating55/10039/100
Traction49/10049/100
Team70/100Not published
Search visibility25/10034/100
Quality58/10045/100
Agent readinessHow well an AI agent can read and act on the siteD (50/100)F (21/100)
Domain ratingLink authority, 0-10017/10020/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCuresponseImpact Biotech
HostingGoogle CloudSelf Managed
CMSNot detectedWordPress
FrameworksNot detectedJquery
AnalyticsNot detectedGoogle Analytics 4

Curesponse vs Impact Biotech: common questions

Which is better, Curesponse or Impact Biotech?

On our 0-100 score Curesponse rates higher (55/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.

How do Curesponse and Impact Biotech compare on the numbers?

Curesponse leads on our overall score (55/100 against 39/100), agent readiness (50/100 against 21/100), funding raised ($28.0M against $2.7M), LinkedIn following (2,570 against 1,470). Impact Biotech leads on domain rating (20/100 against 17/100), headcount (42 against 14), headcount growth (+16.9% against -4.3%).

Read the full Curesponse review and pricing or the Impact Biotech review and pricing. You can also browse other Curesponse alternatives we track.